Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chen, R.-J.
Right arrow Articles by Hsieh, C.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, R.-J.
Right arrow Articles by Hsieh, C.-Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 17, No. 2, 463-468, February 2002
© 2002 European Society of Human Reproduction and Embryology

Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies

Ruey-Jien Chen1,3,4, Chien-Ts Chu2, Su-Cheng Huang1, Song-Nan Chow1,3 and Chang-Yao Hsieh1

1 Department of Obstetrics and Gynecology, National Taiwan University Hospital, 2 Department of Microbiology, 3 Center for Optoelectronic Biomedicine, College of Medicine, National Taiwan University, Taipei, Taiwan

BACKGROUND: The aim of this study was to evaluate telomerase activity in tissue from cases of gestational trophoblastic disease (GTD) and in placental tissue from early and late human pregnancies. METHODS: We used a telomeric repeat amplification protocol assay to measure telomerase activity in 132 tissue samples from normal early pregnancies, spontaneous abortions, normal late pregnancies, cases of late-pregnancy intrauterine fetal death, and GTD. RESULTS: Telomerase activity was detected more often in normal early pregnancies and cases of GTD than in spontaneous abortions and normal late pregnancies (P < 0.001). During early gestation, no significant difference in detection rates was found between normal pregnancies and complete hydatidiform mole. As gestational age increased, detection rates for normal pregnancies decreased significantly (P = 0.0001), while for complete hydatidiform mole no significant changes occurred. CONCLUSIONS: Our findings indicate that placental tissue from normal early pregnancies and neoplastic tissue from GTD possess similar levels of telomerase activity. Decreasing regulation of telomerase activity is present in normal pregnancies but not in complete hydatidiform mole. The fact that telomerase activity decreases in cases of fetal demise, and as pregnancy progresses, also suggests that placental senescence may play a role in the development and ageing of the placenta.

Key words: abortion/complete hydatidiform mole/pregnancy/telomerase activity

4 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, National Taiwan University Hospital,7 Chung-Shan South Road, Taipei, Taiwan. E-mail: rjchen{at}ha.mc.ntu.edu.tw

Submitted on April 17, 2001; resubmitted on August 13, 2001


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
H. Nishi, T. Nakada, S. Kyo, M. Inoue, J. W. Shay, and K. Isaka
Hypoxia-Inducible Factor 1 Mediates Upregulation of Telomerase (hTERT)
Mol. Cell. Biol., July 1, 2004; 24(13): 6076 - 6083.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.